RAYMOND JAMES & ASSOCIATES - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 131 filers reported holding ACCELERON PHARMA INC in Q2 2017. The put-call ratio across all filers is 4.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,947,000
+24.5%
11,314
-9.2%
0.00%
+100.0%
Q2 2021$1,564,000
-17.5%
12,467
-10.8%
0.00%
-50.0%
Q1 2021$1,895,000
+19.2%
13,976
+12.5%
0.00%0.0%
Q4 2020$1,590,000
+30.2%
12,427
+14.5%
0.00%0.0%
Q3 2020$1,221,000
+18.3%
10,853
+0.2%
0.00%
+100.0%
Q2 2020$1,032,000
+69.2%
10,831
+59.4%
0.00%0.0%
Q1 2020$610,000
+55.6%
6,793
-8.1%
0.00%
Q4 2019$392,000
+34.7%
7,392
+0.2%
0.00%
Q3 2019$291,000
-4.9%
7,375
-1.1%
0.00%
Q2 2019$306,000
-29.3%
7,455
-19.8%
0.00%
-100.0%
Q1 2019$433,000
+8.0%
9,298
+1.0%
0.00%0.0%
Q4 2018$401,000
-25.0%
9,208
-1.6%
0.00%0.0%
Q3 2018$535,000
+16.1%
9,355
-1.6%
0.00%0.0%
Q2 2018$461,000
+24.3%
9,506
+0.3%
0.00%0.0%
Q1 2018$371,000
-6.1%
9,478
+1.8%
0.00%0.0%
Q4 2017$395,000
+23.4%
9,314
+8.5%
0.00%0.0%
Q3 2017$320,000
+22.6%
8,586
-0.2%
0.00%0.0%
Q2 2017$261,000
+29.9%
8,600
+13.4%
0.00%
Q1 2017$201,0007,5830.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders